Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
Clinical trial NCT06619860 · RECRUITING
Trial details
- NCT number
- NCT06619860
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-18
- Primary completion
- 2027-03-25
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.